The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Role of the retinoblastoma protein in the pathogenesis of human cancer.
Abstract
The retinoblastoma gene (RB-1) was originally identified as the gene involved in hereditary retinoblastoma. However, RB-1 mutations are found in a number of common mesenchymal and epithelial malignancies. The retinoblastoma protein (pRB) acts as a transcriptional regulator of genes involved in DNA synthesis and cell-cycle control. In this regard, the functional interaction between pRB and the E2F transcription factor family appears to be critical. The pRB-E2F interaction is, in turn, regulated by a pathway that includes cyclin D1, cdk4, and p16. Mutations that affect this pathway have been documented in nearly every type of adult cancer. Thus, perturbation of pRB function may be required for the development of cancer. Insights into the biochemical functions of pRB, and its upstream regulators, may form the basis for the development of novel antineoplastic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,920
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
The E2F transcription factor is a cellular target for the RB protein
Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., & Nevins, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90557-f · Cited by 1,412
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 964
Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC
Harbour, J. W., Lai, S.-L., Whang-Peng, J., Gazdar, A. F., Minna, J. D., & Kaye, F. J. (1988) · Science · doi:10.1126/science.2838909 · Cited by 902
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90507-2 · Cited by 897
Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells
Huang, H.-J. S., Yee, J.-K., Shew, J.-Y., Chen, P.-L., Bookstein, R., Friedmann, T., Lee, E. Y.-H. P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3201247 · Cited by 812
Structural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
Gonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 772
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 756
Self-citationGenetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
Retinoblastoma protein switches the E2F site from positive to negative element
Weintraub, S. J., Prater, C. A., & Dean, D. C. (1992) · Nature · doi:10.1038/358259a0 · Cited by 657
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 635
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576
Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., & Chittenden, T. (1992) · Cell · doi:10.1016/0092-8674(92)90214-w · Cited by 557
Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
Shan, B., & Lee, W. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166 · Cited by 530
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518
Self-citationTumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 514
Retinoblastoma: Clues to Human Oncogenesis
Murphree, A. L., & Benedict, W. F. (1984) · Science · doi:10.1126/science.6320372 · Cited by 496
Ludlow, J. W., DeCaprio, J. A., Huang, C.-M., Lee, W.-H., Paucha, E., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90983-5 · Cited by 494
Mechanism of active transcriptional repression by the retinoblastoma protein
Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., & Dean, D. C. (1995) · Nature · doi:10.1038/375812a0 · Cited by 487
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Helin, K., Harlow, E., & Fattaey, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6501 · Cited by 472
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433
Bagchi, S., Weinmann, R., & Raychaudhuri, P. (1991) · Cell · doi:10.1016/0092-8674(91)90558-g · Cited by 426
Friend, S. H., Horowitz, J. M., Gerber, M. R., Wang, X. F., Bogenmann, E., Li, F. P., & Weinberg, R. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9059 · Cited by 415
Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90559-h · Cited by 407
Self-citationCDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Identification of a growth suppression domain within the retinoblastoma gene product.
Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404
Self-citationStructural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng, Y., Eaton, E. N., Picón, M., Roberts, J. M., Lundberg, A. S., Gifford, A. M., Sardet, C., & Weinberg, R. A. (1996) · PubMed · Cited by 378
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J. J., Richards, W. G., Sugarbaker, D. J., & Rollins, B. J. (1995) · PubMed · Cited by 376
Gene for Hereditary Retinoblastoma Assigned to Human Chromosome 13 by Linkage to Esterase D
Sparkes, R. S., Murphree, A. L., Lingua, R. W., Sparkes, M. C., Field, L. L., Funderburk, S. J., & Benedict, W. F. (1983) · Science · doi:10.1126/science.6823558 · Cited by 366
Flemington, E. K., Speck, S. H., & Kaelin, W. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6914 · Cited by 346
Self-citationBenedict, W. F., Murphree, A. L., Banerjee, A., Spina, C. A., Sparkes, M. C., & Sparkes, R. S. (1983) · Science · doi:10.1126/science.6336308 · Cited by 339
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib, Z. A., Matsushime, H., Valentine, M. B., Shapiro, D. N., Sherr, C. J., & Look, A. T. (1993) · PubMed · Cited by 338
Hu, Q. J., Dyson, N., & Harlow, E. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08221.x · Cited by 315
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98734-r · Cited by 312
La Thangue, N. B. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90202-x · Cited by 312
Ichimura, K., Schmidt, E., Goike, H., & Collins, V. P. (1996) · PubMed · Cited by 307
Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M., & Windle, J. J. (1994) · Genes & Development · doi:10.1101/gad.8.11.1300 · Cited by 303
Cyclin A and the retinoblastoma gene product complex with a common transcription factor
Bandara, L. R., Adamczewski, J. P., Hunt, T., & La Thangue, N. B. (1991) · Nature · doi:10.1038/352249a0 · Cited by 274
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
RB kinases and RB-binding proteins: new points of view
Taya, Y. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10070-0 · Cited by 257
The transcription factor E2F is required for S phase during Drosophila embryogenesis.
Duronio, R. J., O'Farrell, P. H., Xie, J. E., Brook, A., & Dyson, N. (1995) · Genes & Development · doi:10.1101/gad.9.12.1445 · Cited by 253
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Sellers, W. R., Rodgers, J. W., & Kaelin, W. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11544 · Cited by 250
Self-citationAltered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.
Yokota, J., Akiyama, T., Fung, Y. K., Benedict, W. F., Namba, Y., Hanaoka, M., Wada, M., Terasaki, T., Shimosato, Y., & Sügimura, T. (1988) · PubMed · Cited by 245
Cell Cycle Regulation of the Murine Cyclin E Gene Depends on an E2F Binding Site in the Promoter
Botz, J., Zerfass-Thome, K., Spitkovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A., & Jansen-Dürr, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3401 · Cited by 245
Mudryj, M., Hiebert, S. W., & Nevins, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07387.x · Cited by 244
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.
He, J., Allen, J. R., Collins, V. P., Allalunis‐Turner, M. J., Godbout, R., Day, R. S., & James, C. D. (1994) · PubMed · Cited by 238
Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma
Godbout, R., Dryja, T. P., Squire, J., Gallie, B. L., & Phillips, R. A. (1983) · Nature · doi:10.1038/304451a0 · Cited by 232
Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L., & Nevins, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05742.x · Cited by 228
The retinoblastoma gene is involved in malignant progression of astrocytomas
Henson, J. W., Schnitker, B. L., Correa, K. M., von Deimling, A., Fassbender, F., Xu, H., Benedict, W. F., Yandell, D. W., & Louis, D. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360505 · Cited by 217
Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation.
Singh, P., Wong, S. H., & Hong, W. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06635.x · Cited by 208
Toguchida, J., Ishizaki, K., Sasaki, M. S., Ikenaga, M., Sugimoto, M., Kotoura, Y., & Yamamuro, T. (1988) · PubMed · Cited by 206
Varley, J. M., Armour, J. A. L., Je, S., Jeffreys, A. J., Ponder, B. A., Tang, A. J., Fung, Y. K., Brammar, W. J., & Ra, W. (1989) · PubMed · Cited by 202
Retinoblastoma: a prototypic hereditary neoplasm.
Knudson, A. G. (1978) · PubMed · Cited by 199
Kaelin, W. G., Ewen, M. E., & Livingston, D. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3761 · Cited by 197
Self-citationHuang, S., Wang, N. P., Tseng, B. Y., Lee, W. H., & Lee, E. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08306.x · Cited by 196
Multiple members of the E2F transcription factor family are the products of oncogenes.
Xu, G., Livingston, D. M., & Krek, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1357 · Cited by 194
He, J., Olson, J. J., & James, C. D. (1995) · PubMed · Cited by 188
The Transcription Factor E2F-1 Is a Downstream Target of RB Action
Qin, X.-Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., & Kaelin, W. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.742 · Cited by 188
Self-citationDirect Transcriptional Repression by pRB and Its Reversal by Specific Cyclins
Bremner, R., Cohen, B. L., Sopta, M., Hamel, P. A., Ingles, C. J., Gallie, B. L., & Phillips, R. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3256 · Cited by 176
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm1097-1145 · Cited by 169
Self-citationCairns, P., Proctor, A. J., & Knowles, M. A. (1991) · PubMed · Cited by 168
Zhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S., Benedict, W. F., & Sekiya, T. (1994) · PubMed · Cited by 168
Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90233-a · Cited by 164
Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3384-3391.1993 · Cited by 161
Molecular characterization of the retinoblastoma susceptibility gene
Goodrich, D. W., & Lee, W.-H. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90021-4 · Cited by 159
Unrestricted cell cycling and cancer
Strauss, M., Lukas, J., & Bartek, J. (1995) · Nature Medicine · doi:10.1038/nm1295-1245 · Cited by 158
Hensel, C. H. (1991) · Lung Cancer · doi:10.1016/0169-5002(91)90108-i · Cited by 156
Phillips, S. M. A., Barton, C., Lee, S. J., Morton, D. G., Wallace, D., Lemoine, N. R., & Neoptolemos, J. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.482 · Cited by 152
Thangue, N. B. L., & Rigby, P. W. J. (1987) · Cell · doi:10.1016/0092-8674(87)90453-3 · Cited by 145
Transcriptional control by E2F
Adams, P. D., & Kaelin, W. G. (1995) · Seminars in Cancer Biology · doi:10.1006/scbi.1995.0013 · Cited by 143
Self-citationExpression of Dominant-Negative Mutant DP-1 Blocks Cell Cycle Progression in G 1
Wu, C., Classon, M., Dyson, N. J., & Harlow, E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3698 · Cited by 139
Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas
Brooks, J. D., Bova, G. S., & Isaacs, W. B. (1995) · The Prostate · doi:10.1002/pros.2990260108 · Cited by 127
Brown, A. G. M., Ross, F. M., Dunne, E., Steel, C. M., & Weir-Thompson, E. M. (1993) · Nature Genetics · doi:10.1038/ng0193-67 · Cited by 124
Adnane, J., Shao, Z., & Robbins, P. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8837 · Cited by 124
Variable mutations of the RB gene in small-cell lung carcinoma.
Mori, N., Yokota, J., Akiyama, T., Sameshima, Y., Okamoto, A., Mizoguchi, H., Toyoshima, K., Sugimura, T., & Terada, M. (1990) · PubMed · Cited by 107
Retinoblastoma gene mutations in primary human prostate cancer
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., & Shuin, T. (1995) · The Prostate · doi:10.1002/pros.2990270604 · Cited by 98
Studies of the retinoblastoma gene in human sarcomas.
Reissmann, P. T., Ma, S., Wh, L., et al. (1989) · PubMed · Cited by 98
Liu, Y., Székely, L., Grandér, D., Söderhäll, S., Juliusson, G., Gahrton, G., Linder, S., & Einhorn, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8697 · Cited by 96
Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus
Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Gilliland, D. G., & Black, P. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.922 · Cited by 88
Inactivation of the retinoblastoma gene in human lymphoid neoplasms
Ginsberg, A., Raffeld, M. A., & Cossman, J. (1991) · Blood · doi:10.1182/blood.v77.4.833.833 · Cited by 87
Retinoblastoma gene mutations in primary human bladder cancer
Miyamoto, H., Shuin, T., Torigoe, S., Iwasaki, Y., & Kubota, Y. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.160 · Cited by 87
Deletion of the retinoblastoma gene in multiple myeloma.
Dao, D., Sawyer, J. R., Epstein, J., Hoover, R. G., Barlogie, B., & Tricot, G. J. K. (1994) · PubMed · Cited by 84
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line
Saito, M., Helin, K., Valentine, M. B., Griffith, B. B., Willman, C. L., Harlow, E., & Look, A. T. (1995) · Genomics · doi:10.1016/0888-7543(95)80118-6 · Cited by 84
Dodson, M. K., Cliby, W. A., Xu, H., Delacey, K., Hu, S., Keeney, G. L., Li, J., Podratz, K. C., Jenkins, R. B., & Benedict, W. F. (1994) · PubMed · Cited by 80
Kelley, M. J., Nakagawa, K., Steinberg, S., Mulshine, J. L., Kamb, A., & Johnson, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.756 · Cited by 80
Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function
Ishizaki, J., Nevins, J. R., & Sullenger, B. A. (1996) · Nature Medicine · doi:10.1038/nm1296-1386 · Cited by 73
Gouyer, V., Gazzéri, S., Brambilla, E. M., Bolon, I., Moro‐Sibilot, D., Perron, P., Benabid, A. L., & Brambilla, C. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580612 · Cited by 68
An E2F dominant negative mutant blocks E1A induced cell cycle progression.
Dobrowolski, S. F., Stacey, D. W., Harter, M. L., Stine, J. T., & Hiebert, S. W. (1994) · PubMed · Cited by 63
Deletion of the human retinoblastoma gene in primary leukemias
Chen, Y., Chen, P., Yeh, S., Tien, H., Wang, C., Tang, J., & Hong, R. (1990) · Blood · doi:10.1182/blood.v76.10.2060.2060 · Cited by 60
xRB as a modulator of transcription
Sellers, W. R., & Kaelin, W. G. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00014-5 · Cited by 51
Self-citationCoexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer
Yamamoto, H., Monden, T., Ikeda, K., Izawa, H., Fukuda, K., Fukunaga, M., Tomita, N., Shimano, T., Shiozaki, H., & Monden, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.238 · Cited by 48
Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells
Liu, Y., Hbyman, M., Wang, Y., Falkmer, S., Hising, C., Székely, L., & Einhorn, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580508 · Cited by 45
Cho, J. H., Noguchi, M., Ochiai, A., et al. (1996) · PubMed · Cited by 40
Lack of expression of tumor-suppressor genes in human malignant glioma cell lines.
Godbout, R., Miyakoshi, J., Dobler, K., Andison, R., MATSUO, K., Allalunis‐Turner, M. J., Takebe, H., & Rs, D. (1992) · PubMed · Cited by 36
The Retinoblastoma Gene (RB-1) Status in Multiple Myeloma: A Report on 35 Cases
Zandecki, M., Facon, T. T. F., Preudhomme, C., et al. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059651 · Cited by 35
Erratum to ‘RB as a modulator of transcription’ [Biochim. Biophys. Acta 1288 (1996) M1–M5]
Sellers, W. R., & Kaelin, W. G. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00035-2 · Cited by 16
Self-citation
Cited by
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“this regulatory machinery act as tumor suppressors or protooncogenes, whose mutations occur so frequently as to prompt speculation that disabling “the RB pathway” may be essential for the formation of cancer cells (Sherr, 1996; Sellers and Kaelin, 1997; Nevins, 2001; Hahn and Weinberg, 2002; Ortega et al., 2002).”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Self-citationFry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236
Metadata
- Authors
- Sellers, W. R., & Kaelin, W. G.
- Venue
- Journal of Clinical Oncology
- Published
- 1997-11
- Volume
- 15
- Issue
- 11
- Pages
- 3301-3312
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1911118961
- Cited by
- 253
- References
- 136
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.